Cegedim SA (EPA:ALCGM)
France · Delayed Price · Currency is EUR 12.60
+0.35 (2.86%)
Apr 2, 2026, 5:35 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €173.48 million as of April 2, 2026. Its market cap has decreased by -2.68% in one year.
Market Cap
173.48M
Enterprise Value
422.78M
Revenue
649.17M
Ranking
n/a
PE Ratio
18.44
Stock Price
€12.60
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 173.48M, an increase of 52.38%. That is a compound annual growth rate of 1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 173.48M | -7.01% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 99.72B |
| EssilorLuxottica Société anonyme | 88.27B |
| Sartorius Stedim Biotech | 16.45B |
| Ipsen | 13.75B |
| Eurobio Scientific Société anonyme | 226.54M |
| Cellectis | 225.40M |
| Sensorion | 215.15M |
| Transgene | 202.63M |